Rolf-Dieter Kortmann

Long-term survival of patients with glioblastoma treated with radiotherapy and lomustine plus temozolomide.

Martin Glas, Michael Weller, Johannes Rieger, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Radiochemotherapy of malignant glioma in adults. Clinical experiences.

Branislav Jeremic, Ludwig Plasswilm, Michael Weller, 2003, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

Strategies to improve the quality of survival for childhood brain tumour survivors.

Stefan Rutkowski, Beate Timmermann, Andreas Wiener, 2015, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial

Martin Glas, Michael Sabel, Jörg-Christian Tonn, 2019, The Lancet.

Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location

Dominik Sturm, Marco Gessi, Torsten Pietsch, 2018, Neuro-oncology.

Radiochemotherapy of Malignant Glioma in Adults

Branislav Jeremic, Ludwig Plasswilm, Michael Weller, 2003, Strahlentherapie und Onkologie.

GEC-ESTRO multicenter phase 3-trial: Accelerated partial breast irradiation with interstitial multicatheter brachytherapy versus external beam whole breast irradiation: Early toxicity and patient compliance.

Richard Pötter, Wolfgang Uter, Tibor Major, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.